SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000920465-17-000074
Filing Date
2017-10-27
Accepted
2017-10-27 17:24:38
Documents
7
Effectiveness Date
2017-10-27

Document Format Files

Seq Description Document Type Size
1 S-8 s-82017.htm S-8 181067
2 EXHIBIT 5.1 s-8exhibit51.htm EX-5.1 8889
3 EXHIBIT 23.1 s-8exhibit231.htm EX-23.1 3020
4 image1a04.jpg GRAPHIC 19299
5 image2a01.jpg GRAPHIC 11015
6 image3a01.jpg GRAPHIC 19284
7 squar.jpg GRAPHIC 27403
  Complete submission text file 0000920465-17-000074.txt   278827
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-221197 | Film No.: 171160270
SIC: 2836 Biological Products, (No Diagnostic Substances)